Anpirtoline hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAnpirtoline hydrochloride
Drug Alias NameD-16949
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsDepressive Disorder, MajorPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEvonik Industries Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvonik Industries Ag
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorPain

Other Information

ATC CodeN/A
Related LinksN/A